There is obviously a chance this could happen..
I'm not sure punters realise just how big these results are. It provides a clear and defined pathway for multiple product options, including Acne.
As for the RAP fiasco, we have completely different boards.
RAP had an amateur management for mine. They were not commercially savvy whatsoever nor did they have the necessary experience at that level.
BOT has a board that has been there and done this before. Just need to look at Vinnie and what his last deal was worth when he was involved with the Anacor sale to Pfizer. Matt has also been involved in commercial sales before if you check his history.
Any sale would surely command a value in the billions as revenue from SB should start to roll in within 12 months, so BOT is not as pressured as other BIO's to sell out for a quick dollar.
This remains the most undervalued stock on the ASX.
There is obviously a chance this could happen.. I'm not sure...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.015(4.76%) |
Mkt cap ! $597.3M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.3¢ | $1.265M | 3.862M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 129446 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 131308 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |